Camlin Fine Sciences Limited (BOM:532834)

Camlin Fine Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1,086	1,041	802.55	937.42	1,078
Short-Term Investments	-	380.13	-	-	205.53
Cash & Short-Term Investments	1,086	1,421	802.55	937.42	1,284
Cash Growth	-23.60%	77.04%	-14.39%	-26.97%	6.37%
Accounts Receivable	3,730	3,282	2,852	3,046	2,997
Other Receivables	540.32	4.19	-	-	49.64
Receivables	4,270	3,386	2,952	3,147	3,047
Inventory	5,037	5,269	5,127	5,681	3,709
Prepaid Expenses	160.02	145.04	82.67	113.88	89.04
Other Current Assets	1,811	1,613	1,042	998.16	806.88
Total Current Assets	12,365	11,834	10,007	10,878	8,935
Property, Plant & Equipment	6,579	6,536	8,023	8,344	7,403
Long-Term Investments	302.62	229.69	78.76	79.59	72.26
Goodwill	2,334	474.67	470.77	527.93	527.93
Other Intangible Assets	30.33	38.58	34.35	58.28	156.12
Long-Term Deferred Tax Assets	873.84	650.32	405.03	299.75	363.81
Long-Term Deferred Charges	258.41	63.69	93.77	75.8	75.78
Other Long-Term Assets	495.4	410.68	404.61	337.08	466.96
Total Assets	23,239	20,238	19,517	20,601	18,001

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	5,052	4,067	3,246	2,884	2,338
Accrued Expenses	158.43	193.97	207.74	198.99	201.72
Short-Term Debt	2,231	2,415	2,335	2,333	1,810
Current Portion of Long-Term Debt	1,424	1,063	914.78	1,382	545.93
Current Portion of Leases	176.1	105.2	82.14	66.27	60.09
Current Income Taxes Payable	0.76	22.08	1.86	142.5	65.42
Current Unearned Revenue	0.3	0.39	0.39	0.39	-
Other Current Liabilities	701.96	594.87	534.83	923.3	931.41
Total Current Liabilities	9,744	8,462	7,323	7,930	5,953
Long-Term Debt	3,026	2,683	3,327	4,081	3,876
Long-Term Leases	344.02	251.36	171.6	143.31	170.13
Long-Term Unearned Revenue	4.83	5.63	6.77	6.82	8.52
Pension & Post-Retirement Benefits	-	1.62	1.4	1.14	-
Long-Term Deferred Tax Liabilities	39.08	33.1	68.37	151.04	103.08
Other Long-Term Liabilities	72.75	53.22	49.66	47.01	239.59
Total Liabilities	13,231	11,490	10,948	12,360	10,350

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	192.09	187.92	167.47	157.09	156.98
Additional Paid-In Capital	8,134	7,114	4,902	3,827	3,819
Retained Earnings	1,642	1,250	2,542	3,280	2,578
Comprehensive Income & Other	440.64	464.74	1,036	930.02	925.74
Total Common Equity	10,409	9,017	8,648	8,194	7,479
Minority Interest	-400.74	-268.94	-78	47.1	171.19
Shareholders' Equity	10,008	8,748	8,570	8,241	7,651
Total Liabilities & Equity	23,239	20,238	19,517	20,601	18,001

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	7,201	6,518	6,830	8,005	6,463
Net Cash (Debt)	-6,115	-5,097	-6,028	-7,068	-5,179
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-31.85	-29.44	-35.17	-41.70	-36.11
Filing Date Shares Outstanding	192.09	187.92	167.47	157.09	156.98
Total Common Shares Outstanding	192.09	187.92	167.47	157.09	156.98
Working Capital	2,621	3,372	2,684	2,948	2,983
Book Value Per Share	54.19	47.98	51.64	52.16	47.64
Tangible Book Value	8,044	8,503	8,142	7,608	6,795
Tangible Book Value Per Share	41.88	45.25	48.62	48.43	43.29
Land	61.96	84.42	33.27	32.96	31.17
Buildings	1,305	1,288	1,098	1,085	717.67
Machinery	8,192	9,807	9,212	8,807	5,870
Construction In Progress	328.52	97.27	455.65	408.36	2,147
Leasehold Improvements	201.37	146.38	84.16	67.75	58.77

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error